Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Contract Win

22 May 2007 07:00

Embargoed Release: 07:00hrs Tuesday 22nd May 2007

Sopheon plc (`Sopheon') ColepCCL Uses Sopheon's Accolade‚® to Enable and Manage Innovation Process Europe's Largest Contract Manufacturer Implements Group-wide Process to Support Proactive Innovation on Behalf of Customers

Sopheon plc, the international software and services company, is pleased to announce that ColepCCL (` the company'), Europe's largest contract manufacturer of personal and household care products and associated packaging solutions, has selected Sopheon's Accolade product life cycle management (PLM) system to support group-wide implementation of the company's innovation management process. The system will be used by ColepCCL's newly instituted Innovation Centre to provide the automated structure for deployment of the process across plant locations in the UK, Germany, Spain, Portugal and Poland.

ColepCCL was formed in July 2004 as a result of the merger between Colep and CCL Custom Manufacturing. The company consists of four product and packaging divisions and employs approximately 2,100 people throughout Europe. Its contract manufacturing operations produce items such as hair gels and sprays, over-the-counter pharmaceutical preparations, oven cleaners, air fresheners, car waxes and veterinary supplies, as well as a wide range of metal and plastic cans, bottles and pumps associated with the packaging and use of these products.

ColepCCL had historically derived the lion's share of its revenues from manufacturing products and supplying tinplate and plastic packaging according to customer specifications, and from then fulfilling product orders. In recent years, as competitive pressure on both product and package manufacturing has emerged from Asia and other regions, ColepCCL has shifted to a strategy of proactive innovation. Based on this charter, the company's contracts increasingly center on the development of new products and solutions, thereby positioning ColepCCL as an integral partner in the customers' innovation efforts.

In early 2006 ColepCCL established the Innovation Centre to foster creativity and innovation. The Centre is run autonomously, reporting to the ColepCCL Board and providing services to all divisions of the company. A central aspect of the Centre's charter is to coordinate and support implementation of a common innovation process across ColepCCL's geographically decentralized infrastructure of business units. The Centre was assisted in the design and implementation of the process, a variation of the widely used Stage-Gate‚® methodology, by Lisbon-based Inogate. Inogate, a consultant that specializes in enterprise innovation, is a Sopheon partner. It introduced Sopheon's Accolade to ColepCCL as a support solution that would enable the company to automate and more effectively manage its innovation system. Accolade was subsequently chosen over competing solutions due to such considerations as its ease-of-use, the speed and ease with which it can be implemented, and because of a broad mix of advantages stemming from the fact that the Sopheon software is specifically designed to support the process of innovation.

"ColepCCL is committed to reshaping the packaging industry," said Grant A. Coupland, leader of the Innovation Centre. "Our strategy for achieving this goal is to raise our value to customers by leading in the turnkey development of innovative solutions and services. Accolade gives us a unified, sustainable process structure that will enable our business units to effectively innovate with a local focus, but also operate in alignment with the overarching objectives and best practices of the group. Accolade is a cornerstone of ColepCCL's foundation for innovation excellence."

"When ColepCCL came to us, they had a clear vision of the type of process they wanted to support their innovation initiative," said Paulo Janeiro, chief executive officer of Inogate. "Based on that vision, we completed the technical validation, blue printing, installation and configuration of the system in less than 60 days. Accolade's simplicity and technical integrity were key enablers of the speed with which that implementation was executed. The resulting robust, global innovation management process positions ColepCCL to assume a position of innovation leadership within its industry for a long time to come."

Accolade‚® is a registered trademark of Sopheon plc.

Stage-Gate‚® is a registered trademark of the Product Development Institute.

All other trademarks and registered trademarks are the sole property of their respective owners.

About ColepCCL

ColepCCL is part of the RAR Group, one of the largest economic groups in Portugal, registering a turnover of 320 million euros and with approximately 2,100 employees in Europe. ColepCCL supplies its clients - some of the most important consumer goods brands in the world - from its industrial units situated in Portugal, Spain, UK, Poland and Germany. For more information, please visit www.colepccl.com.

About Inogate

Inogate is a consulting firm in enterprise innovation, with offices in Lisbon and Coimbra, Portugal. Inogate is dedicated to the improvement of its customers' innovation performance. The firm's team of experts specializes in the implementation, systematization and optimization of processes that increase the ROI from innovation. Inogate developed the KIEL Modeltm , an approach to innovation dynamism that ensures long-term process success. Inogate is the exclusive representative of Sopheon and its Accolade software in Portugal. For more information, please visit www.inogate.pt.

About Sopheon

Sopheon is an international provider of software and services that help organizations improve the business impact of product innovation. Sopheon's Accolade system automates and governs the innovation process, enabling companies to increase revenue and profits from new products. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com.

For further information contact:

Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Sarah Wharry, Nominated Seymour Pierce Limited Tel: +44 (0) 207 107 8000 Adviser Andrew Tan Hansard Group Tel : + 44 (0) 207 245 1100 + 44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010

SOPHEON PLC
Date   Source Headline
30th Jan 201810:27 amRNSIssue of Equity
29th Jan 20187:00 amRNSTrading Update
4th Jan 20182:05 pmRNSSecond Price Monitoring Extn
4th Jan 20182:00 pmRNSPrice Monitoring Extension
4th Jan 20187:00 amRNSTrading Update
22nd Dec 20171:01 pmRNSHolding(s) in Company
22nd Dec 201712:37 pmRNSConversion of Loan Stock
8th Dec 20177:00 amRNSAmendment to the Terms of Convertible Loan Stock
9th Nov 20177:00 amRNSCertis Europe Partners with Sopheon
19th Oct 20177:00 amRNSSopheon Funding Award
11th Oct 201710:44 amRNSDirector/PDMR Shareholding
2nd Oct 20177:00 amRNSIssue of Equity
26th Sep 20177:00 amRNSSopheon "Leader" in Strategic Portfolio Management
5th Sep 20177:00 amRNSSopheon's Accolade Software beyond innovation
24th Aug 20177:00 amRNSHalf Yearly Report
21st Jul 201710:32 amRNSDirector Shareholdings
6th Jul 20177:00 amRNSAccolade Release 11.2
29th Jun 20177:00 amRNSNew Approach to Product Development with Accolade
13th Jun 201712:04 pmRNSDirector Shareholdings
8th Jun 201712:09 pmRNSResult of AGM
8th Jun 20177:00 amRNSAGM Statement
26th May 20174:33 pmRNSIssue of Equity
26th Apr 20173:50 pmRNSIssue of Equity
12th Apr 201712:01 pmRNSIssue of Equity
7th Apr 20171:37 pmRNSDirector Shareholdings
31st Mar 20177:00 amRNSDirector Shareholdings
31st Mar 20177:00 amRNSIssue of Equity
23rd Mar 20177:00 amRNSFinal Results
23rd Feb 20177:00 amRNSAccolade Release 11.1
16th Feb 20177:00 amRNSGrant of Options / PDMR dealing
30th Jan 20177:00 amRNSTrading Update
21st Nov 201611:50 amRNSIssue of Equity
3rd Nov 20168:00 amRNSAccolade Release 11.0
29th Sep 201612:41 pmRNSIssue of Equity
22nd Sep 20169:09 amRNSIssue of Equity
15th Sep 20163:09 pmRNSIssue of Equity
25th Aug 20167:00 amRNSHalf Yearly Report
28th Jul 20165:01 pmRNSHolding(s) in Company
26th Jul 201610:49 amRNSHolding(s) in Company
12th Jul 201610:48 amRNSHolding(s) in Company
29th Jun 20165:32 pmRNSDirector Dealing
16th Jun 20164:22 pmRNSDirector Dealing
14th Jun 20164:18 pmRNSDirector Dealing
10th Jun 20162:13 pmRNSDirector Dealing
9th Jun 201611:37 amRNSResult of AGM
9th Jun 20167:00 amRNSAGM Statement
31st May 20163:09 pmRNSIssue of Equity
5th May 20161:25 pmRNSHolding(s) in Company
4th May 20167:00 amRNSAccolade Release 10.3
3rd May 20161:27 pmRNSDirector Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.